Institutional Ownership Erasca, Inc. (ERAS)
This table provides information about the institutional ownership of Erasca, Inc. (ERAS). We have compiled data on the 153 institutions that hold shares in the stock, with a total of 227 Million shares, which have been reported (via 13F filing form) to have a value of $342 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
19,391,687
shares
|
$28.3 Million
2.92% of portfolio
|
Q3 2024
Added 19.58%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
16,710,347
shares
|
$24.4 Million
0.03% of portfolio
|
Q4 2024
Reduced 0.72%
|
|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
16,216,216
shares
|
$23.7 Million
6.72% of portfolio
|
Q2 2024
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
12,673,900
shares
|
$18.5 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.63%
|
|
Logos Global Management LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
12,500,000
shares
|
$18.3 Million
4.12% of portfolio
|
Q4 2024
Added 14.68%
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
12,315,004
shares
|
$18 Million
1.29% of portfolio
|
Q4 2024
Reduced 10.55%
|
|
Arch Venture Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
11,055,554
shares
|
$16.1 Million
17.46% of portfolio
|
Q4 2021
New holding
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
10,752,354
shares
|
$15.7 Million
1.03% of portfolio
|
Q4 2024
Added 0.79%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
10,611,346
shares
|
$15.5 Million
0.0% of portfolio
|
Q2 2024
Added 52.0%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
8,857,179
shares
|
$12.9 Million
0.98% of portfolio
|
Q3 2024
New holding
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
7,543,901
shares
|
$11 Million
4.55% of portfolio
|
Q4 2024
Added 8.6%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Feb 13, 2025 Q4 2024 |
6,756,756
shares
|
$9.86 Million
3.31% of portfolio
|
Q2 2024
New holding
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,609,481
shares
|
$9.65 Million
0.0% of portfolio
|
Q4 2024
Added 9.65%
|
|
5 Am Venture Management, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
5,405,404
shares
|
$7.89 Million
6.02% of portfolio
|
Q2 2024
New holding
|
|
Octagon Capital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,136,795
shares
|
$7.5 Million
2.87% of portfolio
|
Q4 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,569,819
shares
|
$6.67 Million
0.0% of portfolio
|
Q4 2024
Added 1.49%
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,390,427
shares
|
$6.41 Million
0.72% of portfolio
|
Q4 2024
Reduced 9.98%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
4,288,369
shares
|
$6.26 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.63%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
4,177,900
shares
|
$6.1 Million
0.01% of portfolio
|
Q4 2024
Added 73.32%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
4,147,275
shares
|
$6.06 Million
0.08% of portfolio
|
Q4 2024
Added 0.2%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
2,801,630
shares
|
$4.09 Million
0.0% of portfolio
|
Q4 2024
Reduced 13.27%
|
|
Ah Equity Partners Bio Ii, L.L.C.
Menlo Park, CA |
Nov 14, 2022 Q3 2022 |
2,500,000
shares
|
$3.65 Million
13.59% of portfolio
|
Q4 2021
New holding
|
|
Affinity Asset Advisors, LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
2,499,431
shares
|
$3.65 Million
1.12% of portfolio
|
Q2 2024
New holding
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
2,162,162
shares
|
$3.16 Million
0.38% of portfolio
|
Q2 2024
New holding
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
2,111,986
shares
|
$3.08 Million
0.0% of portfolio
|
Q4 2024
Added 74.79%
|